gene

RAN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about RAN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

155Connections
30Hypotheses
30Analyses
50Outgoing
50Incoming

Summary

RAN is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, activates. Associated with Aging, Als, Amyotrophic Lateral Sclerosis. Connected to 73 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolRAN
Chromosome12q24.1
Amino Acids216 aa
Exons8
PathwaysEpigenetic, Notch, Circadian Rhythm, Tumor Microenvironment, Lipid Metabolism
GeneCardsRAN
Human Protein AtlasRAN
2019Partnership with Anthem (now Elevance Health) to deploy AI platform[@anthem]
2020Launch of virtual care services in response to COVID-19 pandemic
2021Acquisition of Hydrogen Health and Livongo assets
2022Workforce reduction of approximately 30%
2023Transition to profitability focus
2024Continued expansion of primary care services
Associated DiseasesAging, Als, Amyotrophic Lateral Sclerosis, Ataxia, Dementia, Huntington
Known Drugs/Compoundsrapamycin, metformin
InteractionsC9ORF72, G3BP1, Rb, RB1, RB1CC1, SMCR8
KG Connections155 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

K Health

company · 2920 words

TDP-43 Proteinopathy

mechanism · 4112 words

Curcumin for Neurodegeneration

therapeutic · 4017 words

Fatal Familial Insomnia

disease · 3953 words

DDX3X Gene

gene · 3778 words

er-stress-neurodegeneration

mechanism · 3696 words

Pathway Diagram

graph TD
    RAN["<b>RAN</b>"]
    Als{"Als"}
    RAN -->|"associated with"| Als
    Ms{"Ms"}
    RAN -->|"interacts with"| Ms
    Amyotrophic_Lateral_Sclerosis{"Amyotrophic Lateral Sclerosis"}
    RAN -->|"interacts with"| Amyotrophic_Lateral_Sclerosis
    Dementia{"Dementia"}
    RAN -->|"associated with"| Dementia
    Ataxia{"Ataxia"}
    RAN -->|"associated with"| Ataxia
    Huntington{"Huntington"}
    RAN -->|"associated with"| Huntington
    RAN -->|"associated with"| Ms
    RAN -->|"associated with"| Amyotrophic_Lateral_Sclerosis
    Inflammation{"Inflammation"}
    RAN -->|"inhibits"| Inflammation
    RAN -->|"regulates"| Als
    Neuroinflammation{"Neuroinflammation"}
    RAN -->|"inhibits"| Neuroinflammation
    RAN -->|"inhibits"| Amyotrophic_Lateral_Sclerosis
    C9ORF72["C9ORF72"]
    C9ORF72 -->|"interacts with"| RAN
    C9ORF72 -->|"associated with"| RAN
    P62["P62"]
    P62 -->|"inhibits"| RAN
    NOTCH3["NOTCH3"]
    NOTCH3 -->|"associated with"| RAN
    EIF2A["EIF2A"]
    EIF2A -->|"inhibits"| RAN
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    NEURODEGENERATIVE_DISEASES -->|"associated with"| RAN
    EIF2A -->|"activates"| RAN
    ATG["ATG"]
    ATG -->|"associated with"| RAN
    FTLD["FTLD"]
    FTLD -->|"contributes to"| RAN
    NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"]
    NEURODEGENERATIVE_DISORDERS -->|"associated with"| RAN
    style RAN fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (102)

TargetRelationTypeStr
Alsassociated_withdisease0.75
Amyotrophic Lateral Sclerosisassociated_withdisease0.75
ATGassociated_withgene0.70
AMYOTROPHIC LATERAL SCLEROSISassociated_withgene0.70
RNAregulatesgene0.70

Incoming (53)

SourceRelationTypeStr
C9ORF72associated_withgene0.70
ATGassociated_withgene0.70
C9ORF72interacts_withgene0.60
P62inhibitsgene0.60
NOTCH3associated_withgene0.60

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop transcranial focused ultrasound to restore hippo 0.709 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II SST interneurons to block t 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-Dependent Microglial Senescence Transition 0.692 neurodegeneration Gene expression changes in aging mouse b
Closed-loop transcranial focused ultrasound with 40Hz gamma 0.689 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.670 Alzheimer's disease Circuit-level neural dynamics in neurode
Beta-frequency entrainment therapy targeting PV interneuron- 0.669 Alzheimer's disease Circuit-level neural dynamics in neurode
Transcriptional Autophagy-Lysosome Coupling 0.665 neurodegeneration Autophagy-lysosome pathway convergence a
STMN2 Restoration as a Prerequisite for Axon Growth After TD 0.658 neurodegeneration What molecular mechanisms enable functio
Closed-loop transcranial alternating current stimulation to 0.639 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.633 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.633 Alzheimer's disease Circuit-level neural dynamics in neurode
IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microgl 0.632 neuroinflammation How do oligodendrocytes initiate neuroin
Closed-loop transcranial focused ultrasound to restore hippo 0.614 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.612 Alzheimer's disease Circuit-level neural dynamics in neurode
Aryl Hydrocarbon Receptor (AHR) Activation in B Cells Determ 0.612 neuroinflammation How do B cells mechanistically orchestra
STING Antagonism Prevents Acute-to-Chronic Neuroinflammation 0.605 neuroinflammation What molecular mechanisms drive the tran
TREM2-Microglial Clearance Enhancement as Common Mechanism f 0.604 neurodegeneration Why do p300/CBP inhibitors reduce both A
IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral 0.601 neuroinflammation How do B cells mechanistically orchestra
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from 0.588 neurodegeneration How does APOE4's beneficial immune funct
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S 0.576 neurodegeneration What are the cell-type-specific transcri
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl 0.575 neuroscience Circuit-level neural dynamics in neurode
TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis 0.575 neurodegeneration What molecular mechanism causes VCP muta
Parvalbumin Interneuron Vulnerability Links Lactate Transpor 0.569 neurodegeneration What is the molecular mechanism by which
MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CN 0.552 neuropharmacology What determines blood-brain barrier pene
Glymphatic-Mediated Tau Clearance Dysfunction 0.546 neuroscience Circuit-level neural dynamics in neurode
Real-time gamma-guided transcranial focused ultrasound targe 0.538 Alzheimer's disease Circuit-level neural dynamics in neurode
Glymphatic System-Enhanced Antibody Clearance Reversal 0.537 neurodegeneration Blood-brain barrier transport mechanisms
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign 0.533 neuroscience Circuit-level neural dynamics in neurode
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular 0.527 neuroscience Circuit-level neural dynamics in neurode
Membrane Cholesterol Gradient Modulators 0.517 neurodegeneration Lipid raft composition changes in synapt

Mentioning Analyses (30)

Scientific analyses that reference this entity

What are the specific molecular determinants that govern tau strain selection du

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.583

What are the cell-type-specific transcriptomic signatures of vulnerability in SE

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.576

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

drug delivery | 2026-04-15 | 0 hypotheses

What is the temporal sequence of TREM2 signaling transition from protective to i

neuroimmunology | 2026-04-15 | 2 hypotheses Top: 0.674

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammati [PMID:37678798] Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang Cell Mol Gastroenterol Hepatol 2024 1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia J Inflamm Res 2022 1
Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and inv [PMID:35176466] Zhang L, Liang B, Xu H, Gong Y, Hu W, Ji J Ethnopharmacol 2022 1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818] Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Mech Ageing Dev 2021 1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] Wang Y, An H, Liu T, Qin C, Sesaki H, Gu Cell Rep 2019 1
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] Song X, Zhu S, Chen P, Hou W, Wen Q, Liu Curr Biol 2018 1
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. [PMID:28802038] Ulland TK, Song WM, Huang SC, Ulrich JD, Cell 2017 1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] Krasemann S, Madore C, Cialic R, Baufeld Immunity 2017 1
Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in gl [PMID:28675664] Cid-Díaz T, Santos-Zas I, González-Sánch J Cachexia Sarcopenia Muscle 2017 1
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and T [PMID:41833042] ["Lyu G", "Li D"] CNS & neurological disorders d 2026 0
Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuro [PMID:41858793] ["Wang R", "Feng Y", "Zhou Z", "Jiang J" Frontiers in aging neuroscienc 2026 0
Human CSF proteogenomics links genetic variation to neurodegenerative disease pr [PMID:41757182] ["Puerta R", "Garc\u00eda-Gonz\u00e1lez medRxiv : the preprint server 2026 0
PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] Tsai AP, Martin AK, Mi A, Yeh AE, Ramire Molecular neurodegeneration 2026 0
TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] Yang HC, Deng YS, Zhang J, Zhang T, Song J Alzheimers Dis 2026 0
A scalable human-zebrafish xenotransplantation model reveals gastrosome-mediated [PMID:41957412] Villani A, Wittmann J, Wyss T, Mallona I Commun Biol 2026 0
Dual Role of Microglial TREM2 in Neuronal Degeneration and Regeneration After Ax [PMID:41963086] Pottorf TS, Lane EL, Haley-Johnson Z, Uk J Neurosci 2026 0
TREM2-mediated microglial phagocytosis of inhibitory synapses contributes to pro [PMID:41965330] Wang X, Zhou H, Zhai Y, Zhang Y, Cheng Y Cell Death Discov 2026 0
Investigating the Potential of Gene Editing Technologies in Enhancing Stem Cell [PMID:41926312] ["Mehrabadi S"] Current aging science 2026 0